Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of transradial coronary catheterization on upper limb function.
van Leeuwen MA, van Mieghem NM, Lenzen MJ, Selles RW, Hoefkens MF, Zijlstra F, van Royen N. van Leeuwen MA, et al. Among authors: lenzen mj. JACC Cardiovasc Interv. 2015 Apr 20;8(4):515-23. doi: 10.1016/j.jcin.2014.10.025. Epub 2015 Mar 26. JACC Cardiovasc Interv. 2015. PMID: 25819177 Free article.
Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization.
Lenzen M, Scholte op Reimer W, Norekvål TM, De Geest S, Fridlund B, Heikkilä J, Jaarsma T, Mårtensson J, Moons P, Smith K, Stewart S, Strömberg A, Thompson DR, Wijns W. Lenzen M, et al. Eur J Cardiovasc Nurs. 2006 Jun;5(2):115-21. doi: 10.1016/j.ejcnurse.2006.01.003. Epub 2006 Mar 10. Eur J Cardiovasc Nurs. 2006. PMID: 16530486
The ability of high dose rosuvastatin to improve plaque composition in non-intervened coronary arteries: rationale and design of the Integrated Biomarker and Imaging Study-3 (IBIS-3).
Simsek C, Garcia-Garcia HM, van Geuns RJ, Magro M, Girasis C, van Mieghem N, Lenzen M, de Boer S, Regar E, van der Giessen W, Raichlen J, Duckers HJ, Zijlstra F, van der Steen T, Boersma E, Serruys PW; Integrated Biomarker and Imaging Study-3 investigators. Simsek C, et al. EuroIntervention. 2012 Jun 20;8(2):235-41. doi: 10.4244/EIJV8I2A37. EuroIntervention. 2012. PMID: 22717926 Free article.
Life-years gained by smoking cessation after percutaneous coronary intervention.
de Boer SP, Serruys PW, Valstar G, Lenzen MJ, de Jaegere PJ, Zijlstra F, Boersma E, van Domburg RT; interventional cardiologists of the Thoraxcentre 1980 to 1985. de Boer SP, et al. Among authors: lenzen mj. Am J Cardiol. 2013 Nov 1;112(9):1311-4. doi: 10.1016/j.amjcard.2013.05.075. Epub 2013 Jul 25. Am J Cardiol. 2013. PMID: 23891246
Determinants of high cardiovascular risk in relation to plaque-composition of a non-culprit coronary segment visualized by near-infrared spectroscopy in patients undergoing percutaneous coronary intervention.
de Boer SP, Brugaletta S, Garcia-Garcia HM, Simsek C, Heo JH, Lenzen MJ, Schultz C, Regar E, Zijlstra F, Boersma E, Serruys PW. de Boer SP, et al. Among authors: lenzen mj. Eur Heart J. 2014 Feb;35(5):282-9. doi: 10.1093/eurheartj/eht378. Epub 2013 Sep 12. Eur Heart J. 2014. PMID: 24037276
Primary PCI during off-hours is not related to increased mortality.
de Boer SP, Oemrawsingh RM, Lenzen MJ, van Mieghem NM, Schultz C, Akkerhuis KM, van Leeuwen MA, Zijlstra F, van Domburg RT, Serruys PW, Boersma E. de Boer SP, et al. Among authors: lenzen mj. Eur Heart J Acute Cardiovasc Care. 2012 Apr;1(1):33-9. doi: 10.1177/2048872612441581. Eur Heart J Acute Cardiovasc Care. 2012. PMID: 24062885 Free PMC article.
Trial participation as a determinant of clinical outcome: differences between trial-participants and Every Day Clinical Care patients in the field of interventional cardiology.
de Boer SP, van Leeuwen MA, Cheng JM, Oemrawsingh RM, van Geuns RJ, Serruys PW, Boersma E, Lenzen MJ. de Boer SP, et al. Among authors: lenzen mj. Int J Cardiol. 2013 Nov 15;169(4):305-10. doi: 10.1016/j.ijcard.2013.09.011. Epub 2013 Oct 5. Int J Cardiol. 2013. PMID: 24144926 Clinical Trial.
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study.
Diletti R, Karanasos A, Muramatsu T, Nakatani S, Van Mieghem NM, Onuma Y, Nauta ST, Ishibashi Y, Lenzen MJ, Ligthart J, Schultz C, Regar E, de Jaegere PP, Serruys PW, Zijlstra F, van Geuns RJ. Diletti R, et al. Among authors: lenzen mj. Eur Heart J. 2014 Mar;35(12):777-86. doi: 10.1093/eurheartj/eht546. Epub 2014 Jan 6. Eur Heart J. 2014. PMID: 24394380 Free article.
141 results